Novo Nordisk Partners With OpenAI to Accelerate Drug Discovery
Novo Nordisk will integrate OpenAI's AI across its operations to accelerate drug development, including obesity and diabetes treatments.
Novo Nordisk will integrate OpenAI's AI across its operations to accelerate drug development, including obesity and diabetes treatments.